{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T08:26:52Z","timestamp":1792571212936,"version":"4.5.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Regulatory Peptides"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.regpep.2009.03.012","type":"journal-article","created":{"date-parts":[[2009,4,3]],"date-time":"2009-04-03T08:31:12Z","timestamp":1238747472000},"page":"11-17","source":"Crossref","is-referenced-by-count":339,"title":["Opioid receptors in the gastrointestinal tract"],"prefix":"10.1016","volume":"155","author":[{"given":"Peter","family":"Holzer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.regpep.2009.03.012_bib1","series-title":"Discoveries in Pharmacology","first-page":"357","article-title":"Analgesia up to the twentieth century","volume":"vol. 1","author":"Holzer","year":"1983"},{"key":"10.1016\/j.regpep.2009.03.012_bib2","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF03020955","article-title":"In the arms of Morpheus: the development of morphine for postoperative pain relief","volume":"47","author":"Hamilton","year":"2000","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.regpep.2009.03.012_bib3","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s00210-006-0051-8","article-title":"Translating Trendelenburg; back to the future","volume":"373","author":"Lammers","year":"2006","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.regpep.2009.03.012_bib4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF01862644","article-title":"Physiological and pharmacological investigations of small intestinal peristalsis","volume":"81","author":"Trendelenburg","year":"1917","journal-title":"Arch Exp Pathol Pharmakol"},{"key":"10.1016\/j.regpep.2009.03.012_bib5","first-page":"78","article-title":"Pain, the protective system and combinations with morphine-like effect","volume":"109","author":"Schaumann","year":"1959","journal-title":"Wien Med Wschr"},{"key":"10.1016\/j.regpep.2009.03.012_bib6","first-page":"119","article-title":"The action of morphine and related substances on contraction and on acetylcholine output of coaxially stimulated guinea-pig ileum","volume":"11","author":"Paton","year":"1957","journal-title":"Br J Pharmacol"},{"issue":"Suppl 2","key":"10.1016\/j.regpep.2009.03.012_bib7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1743-3150.2004.00554.x","article-title":"Function of opioids in the enteric nervous system","volume":"16","author":"Wood","year":"2004","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.regpep.2009.03.012_bib8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/257185a0","article-title":"Opiate receptors in normal and drug-altered brain function","volume":"257","author":"Snyder","year":"1975","journal-title":"Nature"},{"key":"10.1016\/j.regpep.2009.03.012_bib9","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/258577a0","article-title":"Identification of two related pentapeptides from the brain with potent opiate agonist activity","volume":"258","author":"Hughes","year":"1975","journal-title":"Nature"},{"key":"10.1016\/j.regpep.2009.03.012_bib10","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1476-5381.1977.tb07557.x","article-title":"The distribution of methionine-enkephalin and leucine-enkephalin in the brain and peripheral tissues","volume":"61","author":"Hughes","year":"1977","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.regpep.2009.03.012_bib11","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0031-6997(25)00012-2","article-title":"Endogenous and exogenous opioids in the control of gastrointestinal motility and secretion","volume":"40","author":"Kromer","year":"1988","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.regpep.2009.03.012_bib12","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0163-7258(95)02053-5","article-title":"Insights into opioid action in the intestinal tract","volume":"69","author":"De Luca","year":"1996","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.regpep.2009.03.012_bib13","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.neulet.2003.12.004","article-title":"Opioids and opioid receptors in the enteric nervous system: from a problem in opioid analgesia to a possible new prokinetic therapy in humans","volume":"361","author":"Holzer","year":"2004","journal-title":"Neurosci Lett"},{"issue":"Suppl 2","key":"10.1016\/j.regpep.2009.03.012_bib14","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1743-3150.2004.00556.x","article-title":"The role of endogenous opiates in the control of gastrointestinal motility: predictions from in vitro modelling","volume":"16","author":"Sanger","year":"2004","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.regpep.2009.03.012_bib15","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1517\/13543784.16.2.181","article-title":"Treatment of opioid-induced gut dysfunction","volume":"16","author":"Holzer","year":"2007","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.regpep.2009.03.012_bib16","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1146\/annurev.pa.25.040185.001341","article-title":"The central and peripheral influences of opioids on gastrointestinal propulsion","volume":"25","author":"Manara","year":"1985","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.regpep.2009.03.012_bib17","first-page":"647","article-title":"The gut as a neurological organ","volume":"113","author":"Holzer","year":"2001","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.regpep.2009.03.012_bib18","series-title":"The enteric nervous system","author":"Furness","year":"2006"},{"key":"10.1016\/j.regpep.2009.03.012_bib19","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2165\/00003495-200363070-00003","article-title":"Opioid-induced bowel dysfunction: pathophysiology and potential new therapies","volume":"63","author":"Kurz","year":"2003","journal-title":"Drugs"},{"issue":"Suppl 2","key":"10.1016\/j.regpep.2009.03.012_bib20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1743-3150.2004.00553.x","article-title":"The opioid system in the gastrointestinal tract","volume":"16","author":"Sternini","year":"2004","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.regpep.2009.03.012_bib21","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0304-3940(92)90748-V","article-title":"Sites of action of morphine on the ascending excitatory reflex in the guinea-pig small intestine","volume":"144","author":"Tonini","year":"1992","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.regpep.2009.03.012_bib22","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/j.1476-5381.1992.tb14448.x","article-title":"Modulation of peristalsis in the guinea-pig isolated small intestine by exogenous and endogenous opioids","volume":"106","author":"Waterman","year":"1992","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.regpep.2009.03.012_bib23","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1159\/000007707","article-title":"Morphine contracts the guinea pig ileal circular muscle by interfering with a nitric oxide mediated tonic inhibition","volume":"60","author":"Lenard","year":"1999","journal-title":"Digestion"},{"key":"10.1016\/j.regpep.2009.03.012_bib24","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/BF00498980","article-title":"Inhibition of stimulated fluid secretion in the rat small and large intestine by opiate agonists","volume":"306","author":"Beubler","year":"1979","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.regpep.2009.03.012_bib25","first-page":"79","article-title":"Antisecretory activity of opiates in vitro and in vivo in man","volume":"84","author":"Turnberg","year":"1983","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.regpep.2009.03.012_bib26","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/sj.bjp.0704527","article-title":"Involvement of \u03bc- and \u03ba-, but not \u03b4-, opioid receptors in the peristaltic motor depression caused by endogenous and exogenous opioids in the guinea-pig intestine","volume":"135","author":"Shahbazian","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.regpep.2009.03.012_bib27","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/0016-5085(83)90435-3","article-title":"Morphine tissue levels and reduction of gastrointestinal transit in rats. Correlation supports primary action site in the gut","volume":"85","author":"Bianchi","year":"1983","journal-title":"Gastroenterology"},{"key":"10.1016\/j.regpep.2009.03.012_bib28","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1365-2982.2005.00640.x","article-title":"Alvimopan, a selective peripherally acting \u03bc-opioid antagonist","volume":"17","author":"Camilleri","year":"2004","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.regpep.2009.03.012_bib29","doi-asserted-by":"crossref","first-page":"531","DOI":"10.2217\/14750708.5.4.531","article-title":"Methylnaltrexone for the management of unwanted peripheral opioid effects","volume":"5","author":"Holzer","year":"2008","journal-title":"Therapy"},{"key":"10.1016\/j.regpep.2009.03.012_bib30","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/BF01308172","article-title":"Effects of the prodrug loperamide oxide, loperamide, and placebo on jejunal motor activity","volume":"37","author":"Stacher","year":"1992","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.regpep.2009.03.012_bib31","doi-asserted-by":"crossref","first-page":"829","DOI":"10.2165\/00003495-200059040-00010","article-title":"Racecadotril","volume":"59","author":"Matheson","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.regpep.2009.03.012_bib32","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0924-8579(99)00151-X","article-title":"Racecadotril: a new approach to the treatment of diarrhoea","volume":"14","author":"Schwartz","year":"2000","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.regpep.2009.03.012_bib33","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1056\/NEJM200008173430703","article-title":"Racecadotril in the treatment of acute watery diarrhea in children","volume":"343","author":"Salazar-Lindo","year":"2000","journal-title":"New Engl J Med"},{"key":"10.1016\/j.regpep.2009.03.012_bib34","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1080\/00365520212495","article-title":"A multinational comparison of racecadotril and loperamide in the treatment of acute watery diarrhoea in adults","volume":"37","author":"Prado","year":"2002","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.regpep.2009.03.012_bib35","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1592\/phco.22.3.240.33552","article-title":"Management of opioid-induced gastrointestinal effects in patients receiving palliative care","volume":"22","author":"Herndon","year":"2002","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.regpep.2009.03.012_bib36","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0885-3924(01)00369-4","article-title":"Low-dose oral naloxone reverses opioid-induced constipation and analgesia","volume":"23","author":"Liu","year":"2002","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.regpep.2009.03.012_bib37","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.pharmthera.2007.09.007","article-title":"The involvement of the \u03bc-opioid receptor in gastrointestinal pathophysiology: therapeutic opportunities for antagonism at this receptor","volume":"117","author":"DeHaven-Hudkins","year":"2008","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.regpep.2009.03.012_bib38","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000165778","article-title":"Meeting the challenges of opioid-induced constipation in chronic pain management \u2014 a novel approach","volume":"83","author":"Reimer","year":"2009","journal-title":"Pharmacology"},{"key":"10.1016\/j.regpep.2009.03.012_bib39","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jpainsymman.2006.12.018","article-title":"Peripherally acting opioid antagonists in the treatment of opiate-related constipation: a systematic review","volume":"34","author":"Becker","year":"2007","journal-title":"J Pain Symptom Manage"},{"issue":"Suppl 2","key":"10.1016\/j.regpep.2009.03.012_bib40","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1743-3150.2004.00555.x","article-title":"Preclinical studies of opioids and opioid antagonists on gastrointestinal function","volume":"16","author":"Greenwood-Van Meerveld","year":"2004","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.regpep.2009.03.012_bib41","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/0304-3940(92)90620-M","article-title":"Oral naloxone reduces constipation but not antinociception from oral morphine in the rat","volume":"142","author":"Jurna","year":"1992","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.regpep.2009.03.012_bib42","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0022-3565(25)24266-5","article-title":"Evidence for the delivery of narcotic antagonists to the colon as their glucuronide conjugates","volume":"244","author":"Simpkins","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.regpep.2009.03.012_bib43","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s10620-006-9563-9","article-title":"Effect of naloxone-3-glucuronide and N-methylnaloxone on the motility of the isolated rat colon after morphine","volume":"52","author":"Reber","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.regpep.2009.03.012_bib44","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0376-8716(95)01153-P","article-title":"Assessment of nalmefene glucuronide as a selective gut opioid antagonist","volume":"39","author":"Cheskin","year":"1995","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.regpep.2009.03.012_bib45","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/026921639601000208","article-title":"An investigation of the ability of oral naloxone to correct opioid-related constipation in patients with advanced cancer","volume":"10","author":"Sykes","year":"1996","journal-title":"Palliat Med"},{"key":"10.1016\/j.regpep.2009.03.012_bib46","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0304-3959(99)00185-2","article-title":"Oral naloxone reverses opioid-associated constipation","volume":"84","author":"Meissner","year":"2000","journal-title":"Pain"},{"key":"10.1016\/j.regpep.2009.03.012_bib47","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejpain.2008.06.012","article-title":"A randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipation","volume":"13","author":"Meissner","year":"2009","journal-title":"Eur J Pain"},{"key":"10.1016\/j.regpep.2009.03.012_bib48","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.jpain.2008.06.014","article-title":"Analgesic efficacy and safety of oxycodone in combination with naloxone as prolonged release tablets in patients with moderate to severe chronic pain","volume":"9","author":"Vondrackova","year":"2008","journal-title":"J Pain"},{"key":"10.1016\/j.regpep.2009.03.012_bib49","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1111\/j.1742-1241.2008.01820.x","article-title":"Patient assessment of a novel therapeutic approach for the treatment of severe, chronic pain","volume":"62","author":"Nadstawek","year":"2008","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.regpep.2009.03.012_bib50","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0014-2999(82)90026-7","article-title":"Antagonism of gut, but not central effects of morphine with quaternary narcotic antagonists","volume":"78","author":"Russell","year":"1982","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.regpep.2009.03.012_bib51","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1517\/13543784.14.4.479","article-title":"Alvimopan","volume":"14","author":"Neary","year":"2005","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.regpep.2009.03.012_bib52","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1517\/13543784.15.5.541","article-title":"Methylnaltrexone, a novel peripheral opioid receptor antagonist for the treatment of opioid side effects","volume":"15","author":"Yuan","year":"2006","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.regpep.2009.03.012_bib53","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1358\/dot.2007.43.9.1086176","article-title":"Alvimopan: a peripherally acting \u03bc-opioid receptor antagonist","volume":"43","author":"Leslie","year":"2007","journal-title":"Drugs Today (Barc)"},{"key":"10.1016\/j.regpep.2009.03.012_bib54","first-page":"90","article-title":"Methylnaltrexone, a new peripheral \u03bc-receptor antagonist for the prevention and treatment of opioid-induced extracerebral side effects","volume":"9","author":"Reichle","year":"2008","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.regpep.2009.03.012_bib55","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00210-007-0146-x","article-title":"The in vitro pharmacology of the peripherally restricted opioid receptor antagonists, alvimopan, ADL 08-0011 and methylnaltrexone","volume":"375","author":"Beattie","year":"2007","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.regpep.2009.03.012_bib56","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.3109\/00498258909043176","article-title":"Variations in demethylation of N-methylnaltrexone in mice, rats, dogs, and humans","volume":"19","author":"Kotake","year":"1989","journal-title":"Xenobiotica"},{"key":"10.1016\/j.regpep.2009.03.012_bib57","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1177\/0091270004273491","article-title":"Tolerability, gut effects, and pharmacokinetics of methylnaltrexone following repeated intravenous administration in humans","volume":"45","author":"Yuan","year":"2005","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.regpep.2009.03.012_bib58","doi-asserted-by":"crossref","DOI":"10.1038\/sj.clpt.6100164","article-title":"Reversal of opioid-induced bladder dysfunction by intravenous naloxone and methylnaltrexone","author":"Rosow","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.regpep.2009.03.012_bib59","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1001\/jama.283.3.367","article-title":"Methylnaltrexone for reversal of constipation due to chronic methadone use: a randomized, controlled trial","volume":"283","author":"Yuan","year":"2000","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.regpep.2009.03.012_bib60","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jpainsymman.2007.12.005","article-title":"Subcutaneous methylnaltrexone for the treatment of opioid-induced constipation in patients with advanced illness: a double-blind, randomized, parallel group, dose-ranging study","volume":"35","author":"Portenoy","year":"2008","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.regpep.2009.03.012_bib61","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1056\/NEJMoa0707377","article-title":"Methylnaltrexone for opioid-induced constipation in advanced illness","volume":"358","author":"Thomas","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.regpep.2009.03.012_bib62","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1517\/13543784.17.9.1365","article-title":"Methylnaltrexone, a new peripherally acting \u03bc-opioid receptor antagonist being evaluated for the treatment of postoperative ileus","volume":"17","author":"Kraft","year":"2008","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.regpep.2009.03.012_bib63","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.brainres.2006.02.092","article-title":"The selective \u03bc opioid receptor antagonist, alvimopan, improves delayed GI transit of postoperative ileus in rats","volume":"1102","author":"Fukuda","year":"2006","journal-title":"Brain Res"},{"key":"10.1016\/j.regpep.2009.03.012_bib64","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1365-2982.2007.01078.x","article-title":"Alvimopan and COX-2 inhibition reverse opioid and inflammatory components of postoperative ileus","volume":"20","author":"Schmidt","year":"2008","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.regpep.2009.03.012_bib65","doi-asserted-by":"crossref","first-page":"27S","DOI":"10.1016\/S0002-9610(01)00784-X","article-title":"Alvimopan (ADL 8-2698) is a novel peripheral opioid antagonist","volume":"182 (Suppl)","author":"Schmidt","year":"2001","journal-title":"Am J Surg"},{"key":"10.1016\/j.regpep.2009.03.012_bib66","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jpain.2004.12.001","article-title":"Alvimopan: an oral, peripherally acting, \u03bc-opioid receptor antagonist for the treatment of opioid-induced bowel dysfunction \u2014 a 21-day treatment-randomized clinical trial","volume":"6","author":"Paulson","year":"2005","journal-title":"J Pain"},{"key":"10.1016\/j.regpep.2009.03.012_bib67","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.pain.2007.11.008","volume":"137","author":"Webster","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.regpep.2009.03.012_bib68","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/01.sla.0000232538.72458.93","article-title":"Alvimopan, for postoperative ileus following bowel resection: a pooled analysis of phase III studies","volume":"245","author":"Delaney","year":"2007","journal-title":"Ann Surg"},{"key":"10.1016\/j.regpep.2009.03.012_bib69","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2036.2006.03150.x","article-title":"Meta-analysis: alvimopan vs. placebo in the treatment of post-operative ileus","volume":"25","author":"Tan","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.regpep.2009.03.012_bib70","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1365-2036.2008.03696.x","article-title":"Clinical trial: alvimopan for the management of postoperative ileus after abdominal surgery: results of an international randomised, double-blind, multicentre, placebo-controlled clinical study","volume":"28","author":"B\u00fcchler","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.regpep.2009.03.012_bib71","doi-asserted-by":"crossref","DOI":"10.1038\/sj.clpt.6100292","article-title":"Pharmacokinetics of alvimopan and its metabolite in healthy volunteers and patients in postoperative ileus trials","author":"Foss","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.regpep.2009.03.012_bib72","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S1542-3565(05)00434-9","article-title":"Effect of alvimopan and codeine on gastrointestinal transit: a randomized controlled study","volume":"3","author":"Gonenne","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.regpep.2009.03.012_bib73","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S0022-3565(24)37902-9","article-title":"Peripheral effects of opioids in a model of chronic intestinal inflammation in mice","volume":"287","author":"Puig","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.regpep.2009.03.012_bib74","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1124\/mol.60.5.894","article-title":"Inflammation enhances \u03bc-opioid receptor transcription and expression in mice intestine","volume":"60","author":"Pol","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.regpep.2009.03.012_bib75","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s004649900085","article-title":"Effect of surgical stress on endogenous morphine and cytokine levels in the plasma after laparoscopoic or open cholecystectomy","volume":"14","author":"Yoshida","year":"2000","journal-title":"Surg Endosc"}],"container-title":["Regulatory Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167011509000731?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167011509000731?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T20:59:08Z","timestamp":1739048348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167011509000731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":75,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S0167011509000731"],"URL":"https:\/\/doi.org\/10.1016\/j.regpep.2009.03.012","relation":{},"ISSN":["0167-0115"],"issn-type":[{"value":"0167-0115","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}